Clinical Trials Browser

lorvotuzumab mertansine × Lymphoid × Clear all

NCT02420873 2018-08-28

An Open-label Phase II Study of Lorvotuzumab Mertansine

LymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Leukemia, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis